Tag: FDA
Understanding the FDA Orange Book: Therapeutic Equivalence and Generic Substitution
Learn how the FDA Orange Book manages therapeutic equivalence and generic substitution to lower drug costs while maintaining safety and efficacy standards.
How Different Countries Regulate NTI Generics: A Global Comparison
NTI generics require strict regulatory oversight due to their narrow safety margin. This article compares how the U.S., EU, Canada, and Japan regulate these high-risk drugs - and why global alignment is urgently needed.